NCBI Taxonomy: 47982

Plexaura homomalla (ncbi_taxid: 47982)

found 45 associated metabolites at species taxonomy rank level.

Ancestor: Plexaura

Child Taxonomies: none taxonomy data.

Prostaglandin A2

(5Z)-7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.214398)


Produced by the seminal vesicles, prostaglandins are a group of lipid compounds that are derived enzymatically from fatty acids. Technically hormones, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. It exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. There is also an increase in DNA content preceeding the G0/G1 peak (indicative of apoptotic body formation) mediated by changes in expression levels of Bax and Bcl-2. Produced by the seminal vessicals: Prostaglandins are a group of lipid compounds that are derived enzymatically from fattyacids. Technically a hormone, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. Prostaglandin A is cyclopentenone and endogenous metabolite derived from arachidonic acid. Exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. As well there is an increase in DNA content preceeding the G0/G1 peak (indicative of apoptic body formation) mediated by changes in expression levels of Bax and Bcl-2.

   

5-Hydroperoxyeicosatetraenoic acid

5-hydroperoxyicosa-2,4,6,8-tetraenoic acid

C20H32O4 (336.2300472)


   

Dinosterol

4 alpha,23,24R-trimethyl-5 alpha-cholest-22-en-3beta-ol

C30H52O (428.4017942)


   

PROSTAGLANDIN A2

9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid

C20H30O4 (334.214398)


   

6,9a,11a-trimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

6,9a,11a-trimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H50O (414.386145)


   

7-{2-[3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl}hept-5-enoic acid

7-{2-[3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl}hept-5-enoic acid

C22H32O5 (376.2249622)


   

(5e)-7-[(1r,2r)-2-[(2e)-oct-2-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

(5e)-7-[(1r,2r)-2-[(2e)-oct-2-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O3 (318.21948299999997)


   

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H52O (416.4017942)


   

6,9a,11a-trimethyl-1-(6-methylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

6,9a,11a-trimethyl-1-(6-methylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C28H50O (402.386145)


   

methyl (5z)-7-[(2s,4ar,5r,7ar)-6-oxo-2-pentyl-hexahydro-2h-cyclopenta[b]pyran-5-yl]hept-5-enoate

methyl (5z)-7-[(2s,4ar,5r,7ar)-6-oxo-2-pentyl-hexahydro-2h-cyclopenta[b]pyran-5-yl]hept-5-enoate

C21H34O4 (350.24569640000004)


   

1-(5,6-dimethylhept-3-en-2-yl)-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

1-(5,6-dimethylhept-3-en-2-yl)-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H50O (414.386145)


   

methyl 7-{6-oxo-2-pentyl-hexahydro-2h-cyclopenta[b]pyran-5-yl}hept-5-enoate

methyl 7-{6-oxo-2-pentyl-hexahydro-2h-cyclopenta[b]pyran-5-yl}hept-5-enoate

C21H34O4 (350.24569640000004)


   

(5z)-7-[(1r,2s)-2-[(1z,3r)-3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

(5z)-7-[(1r,2s)-2-[(1z,3r)-3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C22H32O5 (376.2249622)


   

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-6,9a,11a-trimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-6,9a,11a-trimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H50O (414.386145)


   

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H50O (414.386145)


   

methyl (5e)-7-{2-[(1e)-3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl}hept-5-enoate

methyl (5e)-7-{2-[(1e)-3-(acetyloxy)oct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl}hept-5-enoate

C23H34O5 (390.24061140000003)


   

6,9a,11a-trimethyl-1-(4,5,6-trimethylhept-3-en-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

6,9a,11a-trimethyl-1-(4,5,6-trimethylhept-3-en-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C30H52O (428.4017942)


   

1-(5,6-dimethylheptan-2-yl)-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

1-(5,6-dimethylheptan-2-yl)-6,9a,11a-trimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C29H52O (416.4017942)


   

7-[(1r,2r)-2-[(3s)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

7-[(1r,2r)-2-[(3s)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.214398)


   

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-6,9a,11a-trimethyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,5as,6s,7s,9ar,9bs,11ar)-6,9a,11a-trimethyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol

C28H50O (402.386145)